Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption

Circulation Research

Volumn 84, Issue 7, 1999, Pages 840-845

  Loke, Kit E ^a   McConnell, Patrick I ^a   Tuzman, Joshua M ^a   Shesely, Edward G ^b   Smith, Carolyn J ^a   Stackpole, Christopher J ^a   Thompson, Carl I ^a   Kaley, Gabor ^a   Wolin, Michael S ^a   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Cardiac oxygen consumption; Endothelial nitric oxide synthase derived nitric oxide

Indexed keywords

BRADYKININ; BRADYKININ RECEPTOR; ENDOTOXIN; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE OXYGEN CONSUMPTION; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

EID: 0033574438     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.7.840     Document Type: Article

References (44)

1. Granger DL, Taintor RR, Cook JL, Hibbs JB. Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J Clin Invest. 1980;65:357-370.
2. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988;157:87-94.
3. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med. 1989;169:1543-1555.
4. Granger DL, Lehninger AL. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J Cell Biol. 1982;95: 527-535.
5. Drapier JC, Hibbs JB. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. J Clin Invest. 1986;78:790-797.
6. Cleeter MWJ, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AHV. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 1994;345:50-54.
7. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994;298:249-258.
8. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res. 1994;75:1086-1095.
9. 2 uptake after inhibition of EDRF/NO synthesis. J Appl Physiol. 1994;76:1166-1171.
10. Shen W, Zhang X, Zhao G, Wolin MS, Sessa W, Hintze TH. Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise. Med Sci Sports Exerc. 1995;27:1125-1134.
11. Bernstein RD, Ochoa FY, Xu X, Forfia P, Shen W, Thompson CI, Hintze TH. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res. 1996;79:840-848.
12. Laycock SK, Vogel T, Forfia PR, Tuzman J, Xu XB, Ochoa M, Thompson CI, Nasjletti A, Hintze TH. Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res. 1998;82:1263-1271.
13. Shen W, Hintze TH, Wolin MS. Nitric oxide: an important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation. 1995;92:3505-3512.
14. Xie Y-W, Shen W, Zhao G, Xu X-B, Wolin MS, Hintze TH. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro: implications for the development of heart failure. Circ Res. 1996;79:381-387.
15. MacMicking JD, Nathan C, Hom G, Chartrain N, Trumbauer M, Stevens K, Xie Q-W, Sokol K, Fletcher DS, Hutchinson N, Chen H, Mudgett JS. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995;81:641-650.
16. Shesely EG, Maeda N, Kim H-S, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1996;93:13176-13181.
17. Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen WQ, Kaminski PM, Wolin MS, Hintze TH. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation. Circulation. 1995;91:2982-2988.
18. Umbreit WW, Burris RH, Stauffer JF. The solubility of oxygen. In: Manometric Techniques. 4th ed. Edina, Minn: Burgess Publishing Co; 1964:5-6.
19. Meng W, Ma J, Ayata C, Hara H, Huang PL, Fishman MC, Moskowitz MA. ACh dilates pial arterioles in endothelial and neuronal NOS knockout mice by NO-dependent mechanisms. Am J Physiol. 1996;271: H1145-H1150.
20. 2 receptor knockout mice in vitro. FASEB J. 1998;12:A978. Abstract.
21. Morrissey JJ, McCraken R, Kaneto H, Vehaskari M, Montani D, Klahr S. Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int. 1994;45:998-1005.
22. Buchwalow IB, Schulze W, Kostic MM, Wallukat G, Morwinski R. Intracellular localization of inducible nitric oxide synthase in neonatal rat cardiomyocytes in culture. Acta Histochem. 1997;99:231-240.
23. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A. 1995;92:10688-10692.
24. Faraci FM, Sigmund CD, Shesely EG, Maeda N, Heistad DD. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol. 1998;274:H564-H570.
25. Stoker ME, Gerdes AM, May JF. Regional differences in capillary density and myocyte size in the normal human heart. Anat Rec. 1982; 202:187-191.
26. Rose CP, Goresky CA. Interactions between capillary exchange, cellular entry, and metabolic sequestration processes in the heart. In: Handbook of Physiology, Cardiovascular System, and Microcirculation. Bethesda, Md: American Physiological Society; 1984:781-798.
27. Knowles RG, Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem Sci. 1992;17:399-402.
28. Andries LJ, Brutsaert DL, Sys SU. Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ Res. 1998;82:195-203.
29. Wiemer G, Popp R, Scholkens BA, Gogelein H. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells. Brain Res. 1994;638:261-266.
30. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995;47:25-49.
31. Balligand J-L, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem. 1995;270:14582-14586.
32. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363-380.
33. Rett K, Maerker E, Renn W, van Gilst W, Haering H-U. Perfusion-independent effect of bradykinin and fosinoprilate on glucose transport in Langendorff rat hearts. Am J Cardiol. 1997;80:143A-147A.
34. Feron O, Smith TW, Michel T, Kelly RA. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem. 1997;272:17744-17748.
35. Feron O, Dessy C, Opel DJ, Arstall MA, Kelly RA, Michel T. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem. 1998;273:30249-30254.
36. Ca-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1998;95: 6510-6515.
37. Kanai AJ, Mesaros S, Finkel MS, Oddis CV, Birder LA, Malinski T. β-Adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes. Am J Physiol. 1997;273:C1371-C1377.
38. Bates TE, Loesch A, Bumstock G, Clark JB. Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun. 1996;218:40-44.
39. Kobzik L, Stringer B, Balligand J-L, Reid MB, Stamler JS. Endothelial type nitric oxide synthase in skeletal muscle fibers: mitochondrial relationships. Biochem Biophys Res Commun. 1995;211:375-381.
40. Giulivi C, Poderoso JJ, Boveris A. Production of nitric oxide by mitochondria. J Biol Chem. 1998;273:11038-11043.
41. Tatoyan A, Giulivi C. Purification and characterization of a nitric-oxide synthase from rat liver mitochondria. J Biol Chem. 1998;273: 11038-11043.
42. Maroko PR, Braunwald E. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion. Acta Med Scand Suppl. 1976;587:125-136.
43. Zhang X, Xie Y-W, Nasjletti A, Xu X, Wolin MS, Hintze TH. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation. 1997;95:176-182.
44. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-Nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996; 380:221-226.